Suppr超能文献

海洋天然产物作为新药来源:专利更新综述(2018 年 7 月至 2021 年 7 月)。

Marine natural products as source of new drugs: an updated patent review (July 2018-July 2021).

机构信息

CSIR Unit for Research and Development of Information Products (CSIR-URDIP) "Tapovan" S.No. 113 & 114, NCL Estate, Pashan Road, Pune, 411008, India.

出版信息

Expert Opin Ther Pat. 2022 Mar;32(3):317-363. doi: 10.1080/13543776.2022.2012150. Epub 2022 Jan 5.

Abstract

INTRODUCTION

Marine natural products have aided as rich sources of new bioactive agents. The multiplicity of marine habitations and exclusive ecological conditions of the sea offer mostly unexploited sources of unique biological and chemical entities. In continuation with the authors' previous publication, the present study reviews recently published patents in correlation to the efforts in finding new therapeutically potent chemical and biological entities from marine organisms.

AREAS COVERED

This review summarizes the progress in the field of marine natural products as therapeutic agents based on an analysis of the patents published after June 2018. We have identified 68 unique patent families related to novel marine natural products for this time period. Patent information pertaining to therapeutic applications and clinical studies has been analyzed and reported.

EXPERT OPINION

Marine organisms are excellent producers of secondary metabolites with diverse structures and pharmacological activities. Cumulative increase in the number of patents published during the last few years justifies the importance of this study for spotting new entities as sources of therapeutic agents. The new compounds have been claimed to show a range of activities predominantly anticancer, antimicrobial, anti-inflammatory, and neuroprotection. Majority of the recent patents have been filed by Chinese inventors, and a number of these patents are still in the prosecution stage.

摘要

简介

海洋天然产物是新生物活性物质的丰富来源。海洋的多种栖息地和独特的生态条件提供了大多数尚未开发的独特生物和化学实体的来源。本研究延续了作者之前的出版物,综述了最近发表的专利,以寻找海洋生物中具有治疗潜力的新型化学和生物实体。

涵盖领域

本综述根据 2018 年 6 月后发表的专利分析,总结了海洋天然产物作为治疗剂的领域进展。在此期间,我们确定了 68 个与新型海洋天然产物相关的独特专利家族。对与治疗应用和临床研究相关的专利信息进行了分析和报告。

专家意见

海洋生物是具有多种结构和药理活性的次生代谢产物的优秀生产者。近年来,发表的专利数量不断增加,证明了这项研究对于发现新的治疗剂来源具有重要意义。这些新化合物据称具有多种活性,主要是抗癌、抗菌、抗炎和神经保护作用。最近的专利大多由中国发明人提交,其中一些专利仍在审查阶段。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验